History for some or lesson for all? A systematic review and meta-analysis on the immediate and long-term mental health impact of the 2002-2003 Severe Acute Respiratory Syndrome (SARS) outbreak.
Covid-19
Healthcare workers
Infectious disease
Mental health
Post-traumatic stress disorder
SARS
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
07 04 2021
07 04 2021
Historique:
received:
18
10
2020
accepted:
24
03
2021
entrez:
8
4
2021
pubmed:
9
4
2021
medline:
15
4
2021
Statut:
epublish
Résumé
The aims of this systematic review and meta-analysis are to examine the prevalence of adverse mental health outcomes, both short-term and long-term, among SARS patients, healthcare workers and the general public of SARS-affected regions, and to examine the protective and risk factors associated with these mental health outcomes. We conducted a systematic search of the literature using databases such as Medline, Pubmed, Embase, PsycInfo, Web of Science Core Collection, CNKI, the National Central Library Online Catalog and dissertation databases to identify studies in the English or Chinese language published between January 2003 to May 2020 which reported psychological distress and mental health morbidities among SARS patients, healthcare workers, and the general public in regions with major SARS outbreaks. The literature search yielded 6984 titles. Screening resulted in 80 papers for the review, 35 of which were included in the meta-analysis. The prevalence of post-recovery probable or clinician-diagnosed anxiety disorder, depressive disorder, and post-traumatic stress disorder (PTSD) among SARS survivors were 19, 20 and 28%, respectively. The prevalence of these outcomes among studies conducted within and beyond 6 months post-discharge was not significantly different. Certain aspects of mental health-related quality of life measures among SARS survivors remained impaired beyond 6 months post-discharge. The prevalence of probable depressive disorder and PTSD among healthcare workers post-SARS were 12 and 11%, respectively. The general public had increased anxiety levels during SARS, but whether there was a clinically significant population-wide mental health impact remained inconclusive. Narrative synthesis revealed occupational exposure to SARS patients and perceived stigmatisation to be risk factors for adverse mental health outcomes among healthcare workers, although causality could not be determined due to the limitations of the studies. The chronicity of psychiatric morbidities among SARS survivors should alert us to the potential long-term mental health complications of covid-19 patients. Healthcare workers working in high-risk venues should be given adequate mental health support. Stigmatisation against patients and healthcare workers should be explored and addressed. The significant risk of bias and high degree of heterogeneity among included studies limited the certainty of the body of evidence of the review.
Sections du résumé
BACKGROUND
The aims of this systematic review and meta-analysis are to examine the prevalence of adverse mental health outcomes, both short-term and long-term, among SARS patients, healthcare workers and the general public of SARS-affected regions, and to examine the protective and risk factors associated with these mental health outcomes.
METHODS
We conducted a systematic search of the literature using databases such as Medline, Pubmed, Embase, PsycInfo, Web of Science Core Collection, CNKI, the National Central Library Online Catalog and dissertation databases to identify studies in the English or Chinese language published between January 2003 to May 2020 which reported psychological distress and mental health morbidities among SARS patients, healthcare workers, and the general public in regions with major SARS outbreaks.
RESULTS
The literature search yielded 6984 titles. Screening resulted in 80 papers for the review, 35 of which were included in the meta-analysis. The prevalence of post-recovery probable or clinician-diagnosed anxiety disorder, depressive disorder, and post-traumatic stress disorder (PTSD) among SARS survivors were 19, 20 and 28%, respectively. The prevalence of these outcomes among studies conducted within and beyond 6 months post-discharge was not significantly different. Certain aspects of mental health-related quality of life measures among SARS survivors remained impaired beyond 6 months post-discharge. The prevalence of probable depressive disorder and PTSD among healthcare workers post-SARS were 12 and 11%, respectively. The general public had increased anxiety levels during SARS, but whether there was a clinically significant population-wide mental health impact remained inconclusive. Narrative synthesis revealed occupational exposure to SARS patients and perceived stigmatisation to be risk factors for adverse mental health outcomes among healthcare workers, although causality could not be determined due to the limitations of the studies.
CONCLUSIONS
The chronicity of psychiatric morbidities among SARS survivors should alert us to the potential long-term mental health complications of covid-19 patients. Healthcare workers working in high-risk venues should be given adequate mental health support. Stigmatisation against patients and healthcare workers should be explored and addressed. The significant risk of bias and high degree of heterogeneity among included studies limited the certainty of the body of evidence of the review.
Identifiants
pubmed: 33827499
doi: 10.1186/s12889-021-10701-3
pii: 10.1186/s12889-021-10701-3
pmc: PMC8025448
doi:
Types de publication
Historical Article
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
670Références
Arch Intern Med. 2009 Dec 14;169(22):2142-7
pubmed: 20008700
Can J Psychiatry. 2004 Jun;49(6):391-3
pubmed: 15283534
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Alcohol Alcohol. 2008 Nov-Dec;43(6):706-12
pubmed: 18790829
Psychiatry Clin Neurosci. 2006 Aug;60(4):397-403
pubmed: 16884438
J Formos Med Assoc. 2010 Jul;109(7):524-32
pubmed: 20654792
Int J Nurs Stud. 2006 Feb;43(2):215-25
pubmed: 15927185
Can J Psychiatry. 2007 Apr;52(4):241-7
pubmed: 17500305
Emerg Infect Dis. 2004 Jul;10(7):1206-12
pubmed: 15324539
Ann Acad Med Singap. 2004 Nov;33(6):743-8
pubmed: 15608831
Psychosom Med. 2004 Nov-Dec;66(6):938-42
pubmed: 15564361
Med Care. 2005 Jul;43(7):676-82
pubmed: 15970782
Psychol Med. 2004 Oct;34(7):1197-204
pubmed: 15697046
Infect Control Hosp Epidemiol. 2007 Jan;28(1):75-9
pubmed: 17230391
Arch Intern Med. 2007 Jun 25;167(12):1312-20
pubmed: 17592106
Br J Psychiatry. 2004 Aug;185:127-33
pubmed: 15286063
Psychiatr Serv. 2008 Jan;59(1):91-5
pubmed: 18182545
Crisis. 2010;31(2):86-92
pubmed: 20418214
Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):546-54
pubmed: 19892213
Aust J Physiother. 2005;51(4):213-9
pubmed: 16321128
J Psychosom Res. 2006 May;60(5):513-9
pubmed: 16650592
J Psychiatr Res. 2007 Jan-Feb;41(1-2):119-30
pubmed: 16460760
Chest. 2005 Oct;128(4):2247-61
pubmed: 16236881
Clin Infect Dis. 2004 Oct 15;39(8):1247-9
pubmed: 15486852
Community Ment Health J. 2006 Feb;42(1):53-63
pubmed: 16429250
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33433624
J Psychosom Res. 2008 Feb;64(2):177-83
pubmed: 18222131
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):318-26
pubmed: 19555791
Aging Ment Health. 2006 May;10(3):303-11
pubmed: 16777659
Clin Infect Dis. 2005 Oct 15;41(8):1089-96
pubmed: 16163626
Emerg Med J. 2007 Jan;24(1):12-7
pubmed: 17183035
Lancet Infect Dis. 2020 Jul;20(7):782
pubmed: 32592670
J Occup Environ Med. 2018 Mar;60(3):248-257
pubmed: 29252922
Zhonghua Nei Ke Za Zhi. 2005 Jan;44(1):30-3
pubmed: 15769394
Gen Hosp Psychiatry. 2010 Nov-Dec;32(6):590-8
pubmed: 21112450
Soc Sci Med. 2005 Nov;61(9):2038-46
pubmed: 15913861
J Psychiatr Res. 2021 May;137:673-680
pubmed: 33189356
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jan;25(1):23-6
pubmed: 15061942
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Emerg Infect Dis. 2006 Dec;12(12):1924-32
pubmed: 17326946
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Psychol Med. 2004 Oct;34(7):1187-95
pubmed: 15697045
Psychiatr Q. 2009 Jun;80(2):107-16
pubmed: 19247834
J Pers. 2005 Feb;73(1):261-85
pubmed: 15660679
Compr Psychiatry. 2012 Jan;53(1):15-23
pubmed: 21489421
Int J Nurs Stud. 2007 Sep;44(7):1120-7
pubmed: 16857203
Int J Geriatr Psychiatry. 2008 Dec;23(12):1231-8
pubmed: 18500689
BMJ. 2020 Jun 23;369:m2490
pubmed: 32576550
Lancet. 2003 May 3;361(9368):1486-7
pubmed: 12737853
Ann Acad Med Singap. 2004 Sep;33(5 Suppl):S78-9
pubmed: 15651222
Hong Kong Med J. 2004 Oct;10(5):325-30
pubmed: 15479961
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Can J Psychiatry. 2004 Jun;49(6):385-90
pubmed: 15283533
BMJ. 2020 May 05;369:m1642
pubmed: 32371466
Health Expect. 2016 Jun;19(3):762-72
pubmed: 25220505
Emerg Infect Dis. 2005 Aug;11(8):1297-300
pubmed: 16102324
Can J Psychiatry. 2009 May;54(5):302-11
pubmed: 19497162
J Infect. 2006 Aug;53(2):114-24
pubmed: 16343636
Clin Infect Dis. 2005 Jun 15;40(12):1713-20
pubmed: 15909256
J Nerv Ment Dis. 2004 Dec;192(12):868-71
pubmed: 15583510
Lancet Psychiatry. 2020 Jul;7(7):565-566
pubmed: 32437680
CMAJ. 2004 Mar 2;170(5):793-8
pubmed: 14993174
Mol Psychiatry. 2021 Sep;26(9):4982-4998
pubmed: 33542468
Qual Health Res. 2008 Jun;18(6):729-38
pubmed: 18503014
Epidemiol Infect. 2008 Jul;136(7):997-1007
pubmed: 17662167
BMC Neurol. 2011 Mar 24;11:37
pubmed: 21435231
Can J Psychiatry. 2007 Apr;52(4):233-40
pubmed: 17500304
Psychiatr Serv. 2005 Jan;56(1):76-9
pubmed: 15637196
Br J Psychiatry. 2004 Apr;184:359-60
pubmed: 15056583
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120